Publication Name	World Journal of Orthopedics
Manuscript ID	64788
Country	United Kingdom

Received	2021-02-25 23:38
Peer-Review Started	2021-02-25 23:39
To Make the First Decision
Return for Revision	2021-05-03 03:54
Revised	2021-05-21 21:06
Second Decision	2021-08-05 03:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-08-05 08:47
Articles in Press	2021-08-05 08:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-09-07 11:48
Publish the Manuscript Online	2021-09-14 09:36

ISSN	2218-5836 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Orthopedics
Manuscript Type	Minireviews
Article Title	Current concepts in the management of bisphosphonate associated atypical femoral fractures
Manuscript Source	Invited Manuscript
All Author List	Branavan Rudran, Jonathan Super, Rajan Jandoo, Victor Babu, Soosai Nathan, Edward Ibrahim and Anatole Vilhelm Wiik
Funding Agency and Grant Number
Corresponding Author	Anatole Vilhelm Wiik, BSc, MBBS, MD, Doctor, Lecturer, Department of Surgery and Cancer, Charing Cross Hospital, Fulham Palace Road, 7th Floor East Wing, London W6 8RF, United Kingdom. a.wiik@imperial.ac.uk
Key Words	Bisphosphonates; Atypical fracture; Surgical fixation; Atypical femoral fracture; Osteoporosis
Core Tip	Bisphosphates are a class of drugs used as the mainstay of treatment for osteoporosis. A number of the clinical and radiological features of atypical femoral fractures and osteoporotic femoral fractures are different, indicating that there is a distinct difference in the respective underlying pathophysiology. At the point of presentation of an atypical femoral fracture, bisphosphonate should be discontinued. Currently there is no established treatment guidelines for either complete or incomplete fractures. The evidence suggests that cephalomedullary nailing of the fracture has lower revision rates.
Publish Date	2021-09-14 09:36
Citation	Rudran B, Super J, Jandoo R, Babu V, Nathan S, Ibrahim E, Wiik AV. Current concepts in the management of bisphosphonate associated atypical femoral fractures. World J Orthop 2021; 12(9): 660-671
URL	https://www.wjgnet.com/2218-5836/full/v12/i9/660.htm
DOI	https://dx.doi.org/10.5312/wjo.v12.i9.660

Full Article (PDF)	WJO-12-660.pdf
Full Article (Word)	WJO-12-660.docx
Manuscript File	64788_Auto_Edited-JPY.docx
Answering Reviewers	64788-Answering reviewers.pdf
Audio Core Tip	64788-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	64788-Conflict-of-interest statement.pdf
Copyright License Agreement	64788-Copyright license agreement.pdf
Peer-review Report	64788-Peer-review(s).pdf
Scientific Misconduct Check	64788-Scientific misconduct check.pdf
Scientific Editor Work List	64788-Scientific editor work list.pdf